Use of optophoresis as an in vitro predictor of cell response to chemotherapy for chronic lymphocytic leukemia

References

• Keating M, Chiorazzi N, Messmer B, Damle R N, Allen S L, Rai K R, . Biology and treatment of chronic lymphocytic leukemia. Education program book, V C Broudy, J T Prchal, G J Tricot, et al. American Society of Hematology, San Diego 2003; 153–175
   Google Scholar
• Kalil N, Cheson B. Chronic lymphocytic leukemia. Oncologist 1999; 4: 352–369
   PubMedGoogle Scholar
• Chiorazzi N, Rai K R, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352(8)804–815
   PubMed Web of Science ®Google Scholar
• Kaufmann S H, Earnshaw W C. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000; 256: 42–46
   PubMed Web of Science ®Google Scholar
• Houghton J A. Apoptosis and drug response. Curr Opin Oncol 1999; 11: 475–481
   PubMedGoogle Scholar
• Johnson A J, Mone A P, Abhyankar V, Byrd J C. Advances in the therapy of chronic lymphocytic leukemia. Curr Opin Hematol 2003; 10: 297–305
   PubMed Web of Science ®Google Scholar
• Byrd J C, Rai K, Peterson B L, Appelbaum F R, Morrison V A, Kolitz J E, et al. The Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: An updated retrospective comparative analysis of CALGB 9712 and CALGB 9011. Blood May 11, 2004, [Epub ahead of print]
   Web of Science ®Google Scholar
• Hill D L, Montgomery J A. Selective uptake and retention of anticancer agents by sensitive cells. Cancer Chemother Pharmacol 1980; 4: 221–225
   PubMed Web of Science ®Google Scholar
• Goldie J H. Drug resistance. The chemotherapy source book, M C Perry. Lippincott, Williams, and Wilkins, Philadephia 2001; 37–48
   Google Scholar
• Ashkin A, Dziedzic J M, Yamane T. Optical trapping and manipulation of single cells using infrared laser beams. Nature London 1987; 330: 769–771
   PubMed Web of Science ®Google Scholar
• Wang M M, Schnabel C A, Chachisvilis M, Wong R, Paliotti M J, Simons L A, et al. Optical forces for non-invasive cellular analysis. Applied Optics 2003; 42: 1–9
   Google Scholar
• Forster A H, Wang M M, Butler W F, Chachisvilis M, Chung T DY, Esener S C, et al. Use of moving optical gradient fields for analysis of apoptotic cellular responses in a chronic myeloid leukemia cell model. Analytical Biochem 2004; 327: 14–22
   PubMed Web of Science ®Google Scholar
• Cheson B D, Bennett J M, Rai K R, Grever M R, Kay N E, Schiffer C A, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am J Hematol 1988; 29(3)152–163
   PubMed Web of Science ®Google Scholar
• Cheson B D, Bennett J M, Grever M, Kay N, Keating M J, O'Brien S, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87(12)4990–4997
   PubMed Web of Science ®Google Scholar
• Fruehaf J P, Bosanquet A G. In Vitro determination of drug response: A discussion of clinical applications. Principles and practice of oncology updates. 4th ed, V T DeVitta, Jr, S Hellman, S A Rosenberg. Lippincott, Philadelphia 1993; 1–16
   Google Scholar
• Sonis J. How to use and interpret interval likelihood ratios. Family Medicine 1999; 31(6)432–437
   PubMedGoogle Scholar
• Bosanquet A G, McCann S R, Crotty G M. Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay. Acta Haematol 1995; 93(2 – 4)73–79
   PubMed Web of Science ®Google Scholar
• Swets J A. Measuring the accuracy of diagnostic systems. Science 1988; 240(4857)1285–1293
   PubMed Web of Science ®Google Scholar
• Robert J. Chemosensitvity testing: Prediction of response to anticancer drugs using in vitro assays. J Oncol 1999; 2: 198–210
   Google Scholar
• Hamburger A, Salmon S. Primary bioassay of human tumor stem cells. Science 1977; 197: 461–463
   PubMed Web of Science ®Google Scholar
• Weisenthal L M, Dill P L, Kurnick N B, Lippman M E. Comparison of dye-exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res 1983; 43: 258–264
   PubMed Web of Science ®Google Scholar
• Bosanquet A G, Bell P B. Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using the refined DiSC assay methodology. Leukemia Res 1996; 2: 143–153
   Web of Science ®Google Scholar
• Bosanquet A G, Johnson S, Richards S M. Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay. Br J Haematol 1999; 106: 71–77
   PubMed Web of Science ®Google Scholar
• Peng L, Brisco M J, Morley A A. A method for assessing strand breaks in DNA. Anal Biochem 1998; 262(1)9–16
   PubMed Web of Science ®Google Scholar
• Frey T. Nucleic acid dyes for detection of apoptosis in live cells. Cytometry 1995; 21(3)265–274
   PubMedGoogle Scholar
• Morabito F, Callea I, Console G, Stelitano C, Sculli G, Filangeri M, et al. The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemia. Haematologica 1997; 82: 560–565
   PubMed Web of Science ®Google Scholar
• Bellossillo B, Villamor N, Colomer D, Pons G, Montserrat E, Gil J. In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia. Blood 1999; 94: 2836–2843
   PubMed Web of Science ®Google Scholar
• Kivekas I, Vilpo L, Vilpo J. Relationship of in vitro sensitivities tested with nine drugs and two types of irradiation in chronic lymphocytic leukemia. Leukemia Res 2002; 26: 1035–1041
   PubMed Web of Science ®Google Scholar
• Larsson R, Kristensen J, Sandberg C, Nygren P. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia using a fluorometric microculture cytotoxicity assay [FMCA]. Int J Cancer 1992; 50: 177–185
   PubMed Web of Science ®Google Scholar
• Lindelmalm S, Liliemark J, Gruber A, Eriksson S, Karlsson M O, Wang Y, Albertioni F. Comparison of cytotoxicity of 2-chloro-2'arabino-fluoro-2”-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia. J Hematol 2003; 88: 324–332
   Google Scholar
• Kirkpatrick D L, Duke M, Goh T S. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. Leukemia Res 1990; 14: 459–466
   PubMed Web of Science ®Google Scholar
• Ochs R L, Chattopadhyay A, Bratton R, Gabrin M, Burholt D, Kornblith P, Wells A. Phenotypic cell culture assay for predicting anti-cancer response. Preclinica 2004; 2: 205–212
   Google Scholar
• Andreotti P E, Cree L A, Kurbacher K M, Hartmann D M, Linder D, Harel G, et al. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplastin resistance of ovarian carcinoma. Cancer Res 1995; 55: 5276–5282
   PubMed Web of Science ®Google Scholar
• O'Meara A T, Sevin B U. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer. Gyn Oncol 2001; 83: 334–342
   PubMed Web of Science ®Google Scholar
• Weisenthal L M, Kern D H. Prediction of drug resistance in cancer chemotherapy: the Kern and DiSC assays. Oncology [Huntingt] 1991; 5(9)93–103, disc. 104, 111 – 114, 117 – 118
   PubMedGoogle Scholar
• Kern D H, Weisenthal L M. Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures. J Natl Cancer Inst 1990; 82(7)582–588
   PubMed Web of Science ®Google Scholar
• Weisenthal L M. Clinical correlations for cell culture assays based on the concept of total tumor cell kill. Contrib Gynecol Obstet 1994; 19: 82–90
   PubMedGoogle Scholar